Clot-Busting drugs may cut death risk in lung clot patients
NCT ID NCT07374978
First seen Feb 01, 2026 · Last updated Jun 18, 2026 · Updated 25 times
Summary
This study looked at whether giving clot-busting drugs (thrombolysis) to people with a serious but not immediately life-threatening type of lung clot (pulmonary embolism) and a low risk of bleeding could lower their chance of dying within 30 days. The study included 100 patients and tracked deaths and major bleeding events. The goal was to see if the benefits of breaking up the clot outweigh the risks of bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM SUBACUTE MASSIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ain Shams University
Cairo, Abbassia, 00202, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.